Application of Single-Port Robot-Assisted Breast-Conserving Surgery Via Axillary Approach for Breast Cancer.
Xu Yan
100 participants
Dec 31, 2024
INTERVENTIONAL
Conditions
Summary
Evaluate the safety and feasibility of single-port robotic surgery in breast-conserving surgery, compare and analyze the advantages and disadvantages of single-port robotic surgery and open surgery in terms of complications, postoperative complications, perioperative recovery effects, and safety in breast cancer breast-conserving surgery, in order to select a more effective and safe surgical method. Subjects who meet the inclusion criteria will enter the research process, with surgery including SPr-breast-conserving surgery or open-breast-conserving surgery, and the choice of the two surgical methods is based on the patient's financial situation and the availability of equipment;
Eligibility
Inclusion Criteria6
- The patient himself has very high requirements for beauty, and requires no scar on the chest;
- No chest surgery and radiotherapy.
- No contraindications to surgery and anesthesia.
- Clinical I, stage of early breast cancer and the breast has an appropriate volume, can maintain a good breast shape after surgery.
- Patients in the clinical period who meet the standard of breast conservation surgery after preoperative treatment.
- Age: 18 and 65 years old.
Exclusion Criteria5
- Inflammatory breast cancer.
- The tumor is extensive and it's difficult to achieve negative margins or an ideal breast - conserving appearance.
- Diffusely distributed malignant - characteristic calcifications.
- The margin is positive after local extensive tumor resection, and a negative margin in pathological examination still can't be ensured after re - resection.
- The patient refuses.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Breast-conserving surgery for breast cancer using single-port robotic surgery.
Breast-conserving surgery for breast cancer using traditional open surgery.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06738654